Internal Medicine, Infectious Disease · Modesto, CA
NPI
1558668343
Since 2011
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
600 Coffee Rd
Modesto, CA, 95355
Phone (209) 521-6097
Groups this clinician bills Medicare through
Medicare paid, 2024
$195K
1,971 services
Medicare patients, 2024
525
Average age 71
Drug cost, 2024
$1.8M
1,235 prescriptions
Company payments, 2025
$26.48
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thi T Shwe was code 99233 (hospital e&m - subsequent), 1,365 times for 400 patients. In total Thi T Shwe billed 1,971 services in 9 codes, and Medicare paid $195K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,365 | 400 | $92.25 | $126K |
| 99223 Hospital E&M - Initial | Facility | 306 | 264 | $135.67 | $42K |
| 99214 Office E&M - Established | Office | 236 | 123 | $93.60 | $22K |
| 99213 Office E&M - Established | Office | 33 | 26 | $57.87 | $1,910 |
| 99204 Office E&M - New | Office | 25 | 25 | $120.13 | $3,003 |
By year: 2022 $164K for 1,854 services; 2023 $157K for 1,618 services; 2024 $195K for 1,971 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thi T Shwe prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 138 prescriptions and refills. In total Thi T Shwe wrote 1,235 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 138 | 148 | 16 | $609K |
| Descovy Emtricitabine/Tenofov Alafenam | 81 | 95 | 11 | $204K |
| Fluconazole Generic | 74 | 111 | 20 | $7,110 |
| Cephalexin Generic | 54 | 59 | 20 | $823 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 53 | 71 | Under 11 | $278K |
| Ceftriaxone Ceftriaxone Sodium | 50 | 50 | 13 | $1,384 |
| Doxycycline Monohydrate Generic | 48 | 56 | 17 | $1,660 |
| Cefepime Hcl Generic | 45 | 45 | 12 | $5,323 |
| Tivicay Dolutegravir Sodium | 35 | 35 | Under 11 | $81K |
| Vancomycin Hcl Generic | 35 | 36 | 13 | $5,881 |
| Valacyclovir Valacyclovir Hcl | 30 | 38 | Under 11 | $1,632 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 29 | 39 | Under 11 | $180K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 27 | 27 | Under 11 | $97K |
| Daptomycin Generic | 23 | 23 | Under 11 | $4,916 |
| Maraviroc Generic | 21 | 21 | Under 11 | $26K |
Brand drugs: 449 claims; generic drugs: 786 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thi T Shwe $26.48 ($26.48 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $26.48.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $26.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.